RAFAEL HOLDINGS, INC. Business Acquisition, Pro Forma Net Income (Loss)
RAFAEL HOLDINGS, INC. (RFL) reported Business Acquisition, Pro Forma Net Income (Loss) of -$25.64 million for the 6-month period ending 2026-01-31, per its 10-Q filed 2026-03-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-07-31 was -$25.16M.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-04-30 was -$7.64M.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-01-31 was -$13.02M.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2024-10-31 was -$11.70M.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2025 was -$53.84M.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2024 was -$59.27M.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2023 was -$117.23M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-01-31 | -$25.64M 10-Q · filed 2026-03-16 | ||||||
| 2025-07-31 | -$25.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$32.80M derived: sum of 2 quarters · filed 2026-06-11 | -$45.82M derived: sum of 3 quarters · filed 2026-06-11 | -$53.84M 10-K · filed 2025-10-29 | |||
| 2025-04-30 | -$7.64M 10-Q · filed 2026-06-11 | -$20.66M derived: sum of 2 quarters · filed 2026-06-11 | -$28.68M 10-Q · filed 2026-06-11 | -$36.79M derived: sum of 4 quarters · filed 2026-06-11 | |||
| 2025-01-31 | -$13.02M 10-Q · filed 2026-03-16 | -$24.72M derived: sum of 2 quarters · filed 2026-03-16 | -$29.15M derived: sum of 3 quarters · filed 2026-03-16 | -$32.47M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-10-31 | -$11.70M 10-Q · filed 2025-12-12 | -$16.14M derived: sum of 2 quarters · filed 2025-12-12 | -$19.45M derived: sum of 3 quarters · filed 2025-12-12 | ||||
| 2024-07-31 | -$4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$7.75M derived: sum of 2 quarters · filed 2025-10-29 | -$59.27M 10-K · filed 2025-10-29 | -$15.80M 10-K · filed 2024-11-07 | |||
| 2024-04-30 | -$3.31M 10-Q · filed 2025-06-11 | -$3.39M 10-Q · filed 2024-06-14 | -$54.84M 10-Q · filed 2025-06-11 | -$12.13M 10-Q · filed 2024-06-14 | |||
| 2023-10-31 | -$95.24M 10-Q · filed 2024-12-11 | -$100.27M derived: sum of 2 quarters · filed 2024-12-20 | -$107.40M derived: sum of 3 quarters · filed 2024-12-20 | ||||
| 2023-07-31 | -$5.02M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$12.16M derived: sum of 2 quarters · filed 2024-12-20 | -$117.23M 10-K/A · filed 2024-12-20 | ||||
| 2023-04-30 | -$7.14M 10-Q · filed 2024-06-14 | -$112.21M 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |